The Program in Pharmacoepidemiology benefits from generous support from its corporate partners, including Pfizer, Bayer, and other major pharmaceutical companies. These partners have enabled the Harvard T.H. Chan School of Public Health to provide full tuition support to doctoral students annually since the Program’s inception in 1986.
More on funding opportunities here.
